Downloads: 0 | Views: 72
Research Paper | Health Sciences | India | Volume 9 Issue 9, September 2020
An Overview on Human Papillomavirus (HPV) - Associated Cervical Cancer and HPV Vaccination in India
Milan Pramod Toraskar | Dr. Usha Manjunath 
Abstract: Cervical cancer is the second most prevalent disease in women globally, and infection with oncogenic human papillomavirus (HPV) strains, most often HPV 16, is the leading cause for cervical cancer. The goal is to assess the burden of human papillomavirus (HPV) and HPV-related diseases in India, as well as their potential effect. HPV is the cause of nearly all cervical cancer cases, as well as a significant portion of anogenital and head and neck cancers. Cervical cancer is given special attention since it accounts for more than 80% of malignancies caused by HPV infection. Around 70% of all cervical cancer cases in the globe are caused by HPV strains 16 and 18. HPV vaccinations that protect against HPV 16 and 18 infections are now available in India, with the potential to lower the incidence of cervical and anogenital cancers. Objective: The goal of this systematic integrative study is to examine current evidence on cervical cancer screening education, awareness, and barriers in India, as well as to assess barriers to HPV vaccination. Methods: A systematic integrative review study was conducted on published and review literature published between 2015 and 2021 on HPV associated cervical cancer and HPV vaccination in India. A total of 10 studies were included in the review, and their findings have been presented. The descriptive statistical data for cervical cancer (International Classification of Diseases) were mainly obtained from publications. Results: Reaching out to rural populations to educate them about the condition and possible interventions was one of the most difficult tasks. Apart from that, psychological, socio-cultural, economic, and environmental concerns were the main roadblocks. Conclusion: The eradication of cervical cancer in India will be greatly enhanced by a well-balanced mix of effective cervical cancer screening programmes and effective HPV vaccination programmes.
Keywords: Cervical cancer, Cervical cancer Screening Human Papillomavirus, HPV, DNA, RNA, genotype, cervical intraepithelial lesion, cervical cytology, PAP Smear, Vaccination
Edition: Volume 9 Issue 9, September 2020,
Pages: 1585 - 1592